Delivery Order SPE2DB20D2104-SPE2DB23FS30C

Award Date 2/22/23
Potential Completion Date 2/23/23
Potential Value $2.8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a firm-fixed-price delivery order valued at $8,508.04. The contract is for the supply of PREVNAR 13 SYRINGE 0.5ML, a pneumococcal vaccine product, to support the Defense Logistics Agency (DLA) Troop Support Medical. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
The Defense Logistics Agency (DLA) awarded a $18,424.84 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the procurement of PREVNAR 13 syringes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $16,368.12 for the supply of PREVNAR 13 SYRINGE 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of September 28, 2022. The contract is not designated as a set-aside and was awarded through full and open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant...
The federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of PREVNAR 13 syringes (0.5 mL) to the Defense Logistics Agency (DLA). The award, valued at $114,576.84, is a delivery order contract with a firm fixed price. The contract has a performance period ending on March 31, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
This federal contract award, valued at $7,268.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of PREVNAR 13 syringes, a pneumococcal vaccine, and has a final completion date of September 13, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the procurement of PREVNAR 13 SYRINGE 0.5ML medical supplies. The contract, valued at $7,639.03, is a Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of the Prevnar 13 vaccine syringe, 0.5 mL, to the Defense Logistics Agency (DLA). The $13,990.90 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which enables the efficient procurement of pharmaceutical products and medical supplies to support military...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a delivery order valued at $7,646.45 for the supply of PREVNAR 20 SYRINGE 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 12, 2022. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999.00, as...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract, valued at $4,112.99, to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Prevnar 13 syringes (0.5 mL) and has a completion date of November 8, 2022. This contract is not set aside for any specific business type. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This contract award, valued at $13,038.92, is for the delivery of PREVNAR 13 SYRINGE 0.5ML to the Defense Logistics Agency (DLA). The award was made to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies,...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FS30C
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $2,771.09 for the supply of PREVNAR 13 SYRINGE 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition.

Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and medical devices, to support military healthcare programs globally. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 2/27/25, 12:33 PM